-
1
-
-
19944429772
-
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
-
Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, et al. 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307: 223–227.
-
(2005)
Science
, vol.307
, pp. 223-227
-
-
Andries, K.1
Verhasselt, P.2
Guillemont, J.3
Gohlmann, H.W.4
Neefs, J.M.5
Winkler, H.6
Van Gestel, J.7
Timmerman, P.8
Zhu, M.9
Lee, E.10
-
2
-
-
0030452311
-
A mechanism of drug action revealed by structural studies of enoyl reductase
-
Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW. 1996. A mechanism of drug action revealed by structural studies of enoyl reductase. Science 274: 2107–2110.
-
(1996)
Science
, vol.274
, pp. 2107-2110
-
-
Baldock, C.1
Rafferty, J.B.2
Sedelnikova, S.E.3
Baker, P.J.4
Stuitje, A.R.5
Slabas, A.R.6
Hawkes, T.R.7
Rice, D.W.8
-
3
-
-
0028156861
-
InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis
-
Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collins D, de Lisle G, Jacobs WR Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227–230.
-
(1994)
Science
, vol.263
, pp. 227-230
-
-
Banerjee, A.1
Dubnau, E.2
Quemard, A.3
Balasubramanian, V.4
Um, K.S.5
Wilson, T.6
Collins, D.7
De Lisle, G.8
Jacobs, W.R.9
-
5
-
-
79960062811
-
Lessons from seven decades of antituberculosis drug discovery
-
Barry CE. 2011. Lessons from seven decades of antituberculosis drug discovery. Curr Top Med Chem 11: 1216–1225.
-
(2011)
Curr Top Med Chem
, vol.11
, pp. 1216-1225
-
-
Barry, C.E.1
-
6
-
-
0029908204
-
The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol
-
Belanger AE, Besra GS, Ford ME, Mikusova K, Belisle JT, Brennan PJ, Inamine JM. 1996. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci 93: 11919–11924.
-
(1996)
Proc Natl Acad Sci
, vol.93
, pp. 11919-11924
-
-
Belanger, A.E.1
Besra, G.S.2
Ford, M.E.3
Mikusova, K.4
Belisle, J.T.5
Brennan, P.J.6
Inamine, J.M.7
-
7
-
-
0029943128
-
Molecular mechanisms of drug resistance in Mycobacterium tuberculosis
-
Blanchard JS. 1996. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu Rev Biochem 65: 215–239.
-
(1996)
Annu Rev Biochem
, vol.65
, pp. 215-239
-
-
Blanchard, J.S.1
-
8
-
-
79955855454
-
Relationship of pyridoxine and its derivatives to the mechanism of action of isoniazid
-
Boone IU, Woodward KT. 1953. Relationship of pyridoxine and its derivatives to the mechanism of action of isoniazid. Proc Soc Exp Biol Med 84: 292–296.
-
(1953)
Proc Soc Exp Biol Med
, vol.84
, pp. 292-296
-
-
Boone, I.U.1
Woodward, K.T.2
-
9
-
-
0033797547
-
Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides
-
Boshoff HI, Mizrahi V. 2000. Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides. J Bacteriol 182: 5479–5485.
-
(2000)
J Bacteriol
, vol.182
, pp. 5479-5485
-
-
Boshoff, H.I.1
Mizrahi, V.2
-
10
-
-
84871927537
-
Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis
-
Chakraborty S, Gruber T, Barry CE III, Boshoff HI, Rhee KY. 2013. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis. Science 339: 88–91.
-
(2013)
Science
, vol.339
, pp. 88-91
-
-
Chakraborty, S.1
Gruber, T.2
Barry, C.3
Boshoff, H.I.4
Rhee, K.Y.5
-
11
-
-
0001019102
-
Action de l’amide nicotinique sur les bacilles du genre mycobcaterium
-
Chorine V. 1945. Action de l’amide nicotinique sur les bacilles du genre mycobcaterium. C R Hebd Seances Acad Sci 220: 150–151.
-
(1945)
C R Hebd Seances Acad Sci
, vol.220
, pp. 150-151
-
-
Chorine, V.1
-
12
-
-
84872131305
-
Infectious disease. Approval of novel TB drug celebrated—With restraint
-
Cohen J. 2013. Infectious disease. Approval of novel TB drug celebrated—With restraint. Science 339: 130.
-
(2013)
Science
, vol.339
, pp. 130
-
-
Cohen, J.1
-
13
-
-
0018770510
-
Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra
-
Davidson LA, Takayama K. 1979. Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 16: 104–105.
-
(1979)
Antimicrob Agents Chemother
, vol.16
, pp. 104-105
-
-
Davidson, L.A.1
Takayama, K.2
-
14
-
-
78049411009
-
Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates
-
de Carvalho LP, Fischer SM, Marrero J, Nathan C, Ehrt S, Rhee KY. 2010. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem Biol 17: 1122–1131.
-
(2010)
Chem Biol
, vol.17
, pp. 1122-1131
-
-
De Carvalho, L.P.1
Fischer, S.M.2
Marrero, J.3
Nathan, C.4
Ehrt, S.5
Rhee, K.Y.6
-
15
-
-
80955132757
-
Nitazoxanide disrupts membrane potential and intrabacterial pH homeostasis of Mycobacterium tuberculosis
-
de Carvalho LP, Darby CM, Rhee KY, Nathan C. 2011. Nitazoxanide disrupts membrane potential and intrabacterial pH homeostasis of Mycobacterium tuberculosis. ACS Med Chem Lett 2: 849–854.
-
(2011)
ACS Med Chem Lett
, vol.2
, pp. 849-854
-
-
De Carvalho, L.P.1
Darby, C.M.2
Rhee, K.Y.3
Nathan, C.4
-
16
-
-
0028988237
-
Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis
-
Dessen A, Quemard A, Blanchard JS, Jacobs WR Jr, Sacchettini JC. 1995. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267: 1638–1641.
-
(1995)
Science
, vol.267
, pp. 1638-1641
-
-
Dessen, A.1
Quemard, A.2
Blanchard, J.S.3
Jacobs, W.R.4
Sacchettini, J.C.5
-
17
-
-
0014528345
-
Absorption, metabolism and excretion of pyrazinamide in man
-
Ellard GA. 1969. Absorption, metabolism and excretion of pyrazinamide in man. Tubercle 50: 144–158.
-
(1969)
Tubercle
, vol.50
, pp. 144-158
-
-
Ellard, G.A.1
-
19
-
-
0003190187
-
Effect of ethambutol on nucleic acid metabolism in Mycobacterium smegmatis and its reversal by polyamines and divalent cations
-
Forbes M, Kuck NA, Peets EA. 1965. Effect of ethambutol on nucleic acid metabolism in Mycobacterium smegmatis and its reversal by polyamines and divalent cations. J Bacteriol 89: 1299–1305.
-
(1965)
J Bacteriol
, vol.89
, pp. 1299-1305
-
-
Forbes, M.1
Kuck, N.A.2
Peets, E.A.3
-
20
-
-
0001352336
-
The chemical approach to the control of tuberculosis
-
Fox HH. 1952. The chemical approach to the control of tuberculosis. Science 116: 129–134.
-
(1952)
Science
, vol.116
, pp. 129-134
-
-
Fox, H.H.1
-
21
-
-
70349342842
-
The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis
-
Goude R, Amin AG, Chatterjee D, Parish T. 2009. The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother 53: 4138–4146.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 4138-4146
-
-
Goude, R.1
Amin, A.G.2
Chatterjee, D.3
Parish, T.4
-
22
-
-
84876070071
-
Association between embB mutations and ethambutol resistance in Mycobacterium tuberculosis isolates from Cuba and the Dominican Republic: Reproducible patterns and problems
-
Guerrero E, Lemus D, Yzquierdo S, Vilchez G, Munoz M, Montoro E, Takiff H. 2013. Association between embB mutations and ethambutol resistance in Mycobacterium tuberculosis isolates from Cuba and the Dominican Republic: Reproducible patterns and problems. Rev Argent Microbiol 45: 21–26.
-
(2013)
Rev Argent Microbiol
, vol.45
, pp. 21-26
-
-
Guerrero, E.1
Lemus, D.2
Yzquierdo, S.3
Vilchez, G.4
Munoz, M.5
Montoro, E.6
Takiff, H.7
-
23
-
-
62949223223
-
Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue
-
Haagsma AC, Abdillahi-Ibrahim R, Wagner MJ, Krab K, Vergauwen K, Guillemont J, Andries K, Lill H, Koul A, Bald D. 2009. Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue. Antimicrob Agents Chemother 53: 1290–1292.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 1290-1292
-
-
Haagsma, A.C.1
Abdillahi-Ibrahim, R.2
Wagner, M.J.3
Krab, K.4
Vergauwen, K.5
Guillemont, J.6
Ries, K.7
Lill, H.8
Koul, A.9
Bald, D.10
-
25
-
-
77149123917
-
Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor
-
Huitric E, Verhasselt P, Koul A, Andries K, Hoffner S, Andersson DI. 2010. Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor. Antimicrob Agents Chemother 54: 1022–1028.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 1022-1028
-
-
Huitric, E.1
Verhasselt, P.2
Koul, A.3
Ries, K.4
Hoffner, S.5
Ersson, D.I.6
-
27
-
-
0027993499
-
Mechanistic studies of the oxidation of isoniazid by the catalase-peroxidase from Mycobacterium tuberculosis
-
Johnsson K, Schultz PG. 1994. Mechanistic studies of the oxidation of isoniazid by the catalase-peroxidase from Mycobacterium tuberculosis. J Am Chem Soc 116: 7425– 7426.
-
(1994)
J am Chem Soc
, vol.116
-
-
Johnsson, K.1
Schultz, P.G.2
-
29
-
-
34547500013
-
The influence of isoniazid and streptomycin on acid-fastness, tetrazolium reduction, growth, and survival of tubercle bacilli
-
Koch-Weser D, Barclay WR, Ebert RH. 1955. The influence of isoniazid and streptomycin on acid-fastness, tetrazolium reduction, growth, and survival of tubercle bacilli. Am Rev Tuberc 71: 556–565.
-
(1955)
Am Rev Tuberc
, vol.71
, pp. 556-565
-
-
Koch-Weser, D.1
Barclay, W.R.2
Ebert, R.H.3
-
30
-
-
0014062867
-
Pyrazinamide susceptibility and amidase activity of tubercle bacilli
-
Konno K, Feldmann FM, McDermott W. 1967. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis 95: 461–469.
-
(1967)
Am Rev Respir Dis
, vol.95
, pp. 461-469
-
-
Konno, K.1
Feldmann, F.M.2
McDermott, W.3
-
31
-
-
34248998479
-
Diarylquinolines target subunit c of mycobacterial ATP synthase
-
Koul A, Dendouga N, Vergauwen K, Molenberghs B, Vranckx L, Willebrords R, Ristic Z, Lill H, Dorange I, Guillemont J, et al. 2007. Diarylquinolines target subunit c of mycobacterial ATP synthase. Nat Chem Biol 3: 323– 324.
-
(2007)
Nat Chem Biol
, vol.3
-
-
Koul, A.1
Dendouga, N.2
Vergauwen, K.3
Molenberghs, B.4
Vranckx, L.5
Willebrords, R.6
Ristic, Z.7
Lill, H.8
Dorange, I.9
Guillemont, J.10
-
32
-
-
84904260030
-
Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
-
Koul A, Vranckx L, Dhar N, Gohlmann HW, Ozdemir E, Neefs JM, Schulz M, Lu P, Mortz E, McKinney JD, et al. 2014. Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism. Nat Commun 5: 3369.
-
(2014)
Nat Commun
, vol.5
, pp. 3369
-
-
Koul, A.1
Vranckx, L.2
Dhar, N.3
Gohlmann, H.W.4
Ozdemir, E.5
Neefs, J.M.6
Schulz, M.7
Lu, P.8
Mortz, E.9
McKinney, J.D.10
-
33
-
-
33845567402
-
Mode of action of ethambutol on Mycobacterium tuberculosis, strain H37R V
-
Kuck NA, Peets EA, Forbes M. 1963. Mode of action of ethambutol on Mycobacterium tuberculosis, strain H37R V. Am Rev Respir Dis 87: 905–906.
-
(1963)
Am Rev Respir Dis
, vol.87
, pp. 905-906
-
-
Kuck, N.A.1
Peets, E.A.2
Forbes, M.3
-
34
-
-
0034723345
-
Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of inha inhibitor
-
Lei B, Wei CJ, Tu SC. 2000. Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of inha inhibitor. J Biol Chem 275: 2520–2526.
-
(2000)
J Biol Chem
, vol.275
, pp. 2520-2526
-
-
Lei, B.1
Wei, C.J.2
Tu, S.C.3
-
35
-
-
0027262433
-
Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance
-
Levin ME, Hatfull GF. 1993. Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance. Mol Microbiol 8: 277–285.
-
(1993)
Mol Microbiol
, vol.8
, pp. 277-285
-
-
Levin, M.E.1
Hatfull, G.F.2
-
37
-
-
0001703625
-
The effect of pyrazinamide (Aldinamide) on experimental tuberculosis in mice
-
Malone L, Schurr A, Lindh H, Mc KD, Kiser JS, Williams JH. 1952. The effect of pyrazinamide (aldinamide) on experimental tuberculosis in mice. Am Rev Tuberc 65: 511– 518.
-
(1952)
Am Rev Tuberc
, vol.65
-
-
Malone, L.1
Schurr, A.2
Lindh, H.3
Mc, K.D.4
Kiser, J.S.5
Williams, J.H.6
-
38
-
-
0029153735
-
Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation
-
Marcinkeviciene JA, Magliozzo RS, Blanchard JS. 1995. Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation. J Biol Chem 270: 22290–22295.
-
(1995)
J Biol Chem
, vol.270
, pp. 22290-22295
-
-
Marcinkeviciene, J.A.1
Magliozzo, R.S.2
Blanchard, J.S.3
-
39
-
-
0033962136
-
InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II
-
Marrakchi H, Laneelle G, Quemard A. 2000. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 146: 289–296.
-
(2000)
Microbiology
, vol.146
, pp. 289-296
-
-
Marrakchi, H.1
Laneelle, G.2
Quemard, A.3
-
40
-
-
80054918463
-
The medicinal chemistry of tuberculosis chemotherapy
-
Marriner GA, Nayyar A, Uh E, Wong SY, Mukherjee T, Via LE, Carroll M, Edwards RL, Gruber TD, Choi I, et al. 2011. The medicinal chemistry of tuberculosis chemotherapy. Top Med Chem 7: 47–124.
-
(2011)
Top Med Chem
, vol.7
, pp. 47-124
-
-
Marriner, G.A.1
Nayyar, A.2
Uh, E.3
Wong, S.Y.4
Mukherjee, T.5
Via, L.E.6
Carroll, M.7
Edwards, R.L.8
Gruber, T.D.9
Choi, I.10
-
41
-
-
77049188261
-
Activation of pyrazinamide and nicotinamide in acidic environments in vitro
-
McDermott W, Tompsett R. 1954. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc 70: 748–754.
-
(1954)
Am Rev Tuberc
, vol.70
, pp. 748-754
-
-
McDermott, W.1
Tompsett, R.2
-
42
-
-
0025815311
-
Location of the mycolyl ester substituents in the cell walls of mycobacteria
-
McNeil M, Daffe M, Brennan PJ. 1991. Location of the mycolyl ester substituents in the cell walls of mycobacteria. J Biol Chem 266: 13217–13223.
-
(1991)
J Biol Chem
, vol.266
, pp. 13217-13223
-
-
McNeil, M.1
Daffe, M.2
Brennan, P.J.3
-
43
-
-
84960994147
-
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report
-
Middlebrook G. 1954. Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. Am Rev Tuberc 69: 471–472.
-
(1954)
Am Rev Tuberc
, vol.69
, pp. 471-472
-
-
Middlebrook, G.1
-
45
-
-
7244245763
-
Antibiotics at the crossroads
-
Nathan C. 2004. Antibiotics at the crossroads. Nature 431: 899–902.
-
(2004)
Nature
, vol.431
, pp. 899-902
-
-
Nathan, C.1
-
46
-
-
61849182514
-
Taming tuberculosis: A challenge for science and society
-
Nathan C. 2009. Taming tuberculosis: A challenge for science and society. Cell Host Microbe 5: 220–224.
-
(2009)
Cell Host Microbe
, vol.5
, pp. 220-224
-
-
Nathan, C.1
-
47
-
-
50349103195
-
A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis
-
Nathan C, Gold B, Lin G, Stegman M, de Carvalho LP, Vandal O, Venugopal A, Bryk R. 2008. A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis. Tuberculosis (Edinb) 88: S25–S33.
-
(2008)
Tuberculosis (Edinb)
, vol.88
, pp. S25-S33
-
-
Nathan, C.1
Gold, B.2
Lin, G.3
Stegman, M.4
De Carvalho, L.P.5
Vandal, O.6
Venugopal, A.7
Bryk, R.8
-
48
-
-
0035984784
-
Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis
-
Nguyen M, Quemard A, Broussy S, Bernadou J, Meunier B. 2002. Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis. Antimicrob Agents Chemother 46: 2137–2144.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 2137-2144
-
-
Nguyen, M.1
Quemard, A.2
Broussy, S.3
Bernadou, J.4
Meunier, B.5
-
49
-
-
84858790233
-
Innovation: Metabolomics: The apogee of the omics trilogy
-
Patti GJ, Yanes O, Siuzdak G. 2012. Innovation: Metabolomics: The apogee of the omics trilogy. Nat Rev Mol Cell Biol 13: 263–269.
-
(2012)
Nat Rev Mol Cell Biol
, vol.13
, pp. 263-269
-
-
Patti, G.J.1
Yanes, O.2
Siuzdak, G.3
-
51
-
-
79251537963
-
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
-
Pethe K, Sequeira PC, Agarwalla S, Rhee K, Kuhen K, Phong WY, Patel V, Beer D, Walker JR, Duraiswamy J, et al. 2010. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat Commun 1: 57.
-
(2010)
Nat Commun
, vol.1
, pp. 57
-
-
Pethe, K.1
Sequeira, P.C.2
Agarwalla, S.3
Rhee, K.4
Kuhen, K.5
Phong, W.Y.6
Patel, V.7
Beer, D.8
Walker, J.R.9
Duraiswamy, J.10
-
52
-
-
0039832721
-
Antagonism of isoniazid by certain metabolites
-
Pope H. 1953. Antagonism of isoniazid by certain metabolites. Am Rev Tuberc 68: 938–939.
-
(1953)
Am Rev Tuberc
, vol.68
, pp. 938-939
-
-
Pope, H.1
-
53
-
-
35348818394
-
The neutralization of isoniazid activity in Mycobacterium tuberculosis by certain metabolites
-
Pope H. 1956. The neutralization of isoniazid activity in Mycobacterium tuberculosis by certain metabolites. Am Rev Tuberc 73: 735–747.
-
(1956)
Am Rev Tuberc
, vol.73
, pp. 735-747
-
-
Pope, H.1
-
54
-
-
0029000868
-
Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis
-
Quemard A, Sacchettini JC, Dessen A, Vilcheze C, Bittman R, Jacobs WR Jr, Blanchard JS. 1995. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34: 8235–8241.
-
(1995)
Biochemistry
, vol.34
, pp. 8235-8241
-
-
Quemard, A.1
Sacchettini, J.C.2
Dessen, A.3
Vilcheze, C.4
Bittman, R.5
Jacobs, W.R.6
Blanchard, J.S.7
-
55
-
-
50149113470
-
The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
-
Rao SP, Alonso S, Rand L, Dick T, Pethe K. 2008. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci 105: 11945– 11950.
-
(2008)
Proc Natl Acad Sci
, vol.105
-
-
Rao, S.P.1
Alonso, S.2
Rand, L.3
Dick, T.4
Pethe, K.5
-
56
-
-
84861029136
-
Scaling up interventions to achieve global tuberculosis control: Progress and new developments
-
Raviglione M, Marais B, Floyd K, Lonnroth K, Getahun H, Migliori GB, Harries AD, Nunn P, Lienhardt C, Graham S, et al. 2012. Scaling up interventions to achieve global tuberculosis control: Progress and new developments. Lancet 379: 1902–1913.
-
(2012)
Lancet
, vol.379
, pp. 1902-1913
-
-
Raviglione, M.1
Marais, B.2
Floyd, K.3
Lonnroth, K.4
Getahun, H.5
Migliori, G.B.6
Harries, A.D.7
Nunn, P.8
Lienhardt, C.9
Graham, S.10
-
57
-
-
0345133299
-
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance
-
Rawat R, Whitty A, Tonge PJ. 2003. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance. Proc Natl Acad Sci 100: 13881– 13886.
-
(2003)
Proc Natl Acad Sci
, vol.100
-
-
Rawat, R.1
Whitty, A.2
Tonge, P.J.3
-
58
-
-
0032472224
-
Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis
-
Rozwarski DA, Grant GA, Barton DH, Jacobs WR Jr, Sacchettini JC. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279: 98–102.
-
(1998)
Science
, vol.279
, pp. 98-102
-
-
Rozwarski, D.A.1
Grant, G.A.2
Barton, D.H.3
Jacobs, W.R.4
Sacchettini, J.C.5
-
59
-
-
77952356637
-
Tuberculosis: What we don’t know can, and does, hurt us
-
Russell DG, Barry CE III, Flynn JL. 2010. Tuberculosis: What we don’t know can, and does, hurt us. Science 328: 852– 856.
-
(2010)
Science
, vol.328
-
-
Russell, D.G.1
Barry, C.2
Flynn, J.L.3
-
60
-
-
44449139430
-
Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin
-
Safi H, Sayers B, Hazbon MH, Alland D. 2008. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 52: 2027–2034.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 2027-2034
-
-
Safi, H.1
Sayers, B.2
Hazbon, M.H.3
Alland, D.4
-
61
-
-
84885003827
-
Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-b-D-arabinose biosynthetic and utilization pathway genes
-
Safi H, Lingaraju S, Amin A, Kim S, Jones M, Holmes M, McNeil M, Peterson SN, Chatterjee D, Fleischmann R, et al. 2013. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-b-D-arabinose biosynthetic and utilization pathway genes. Nat Genet 45: 1190–1197.
-
(2013)
Nat Genet
, vol.45
, pp. 1190-1197
-
-
Safi, H.1
Lingaraju, S.2
Amin, A.3
Kim, S.4
Jones, M.5
Holmes, M.6
McNeil, M.7
Peterson, S.N.8
Chatterjee, D.9
Fleischmann, R.10
-
62
-
-
13444249851
-
Global strategies to integrate the proteome and metabolome
-
Saghatelian A, Cravatt BF. 2005. Global strategies to integrate the proteome and metabolome. Curr Opin Chem Biol 9: 62–68.
-
(2005)
Curr Opin Chem Biol
, vol.9
, pp. 62-68
-
-
Saghatelian, A.1
Cravatt, B.F.2
-
63
-
-
0015782531
-
Transduction of isoniazid susceptibility-resistance and streptomycin resistance in mycobacteria
-
Saroja D, Gopinathan KP. 1973. Transduction of isoniazid susceptibility-resistance and streptomycin resistance in mycobacteria. Antimicrob Agents Chemother 4: 643–645.
-
(1973)
Antimicrob Agents Chemother
, vol.4
, pp. 643-645
-
-
Saroja, D.1
Gopinathan, K.P.2
-
64
-
-
0029954860
-
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus
-
Scorpio A, Zhang Y. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2: 662–667.
-
(1996)
Nat Med
, vol.2
, pp. 662-667
-
-
Scorpio, A.1
Zhang, Y.2
-
65
-
-
0031020486
-
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis
-
Scorpio A, Lindholm-Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, Zhang Y. 1997. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 41: 540– 543.
-
(1997)
Antimicrob Agents Chemother
, vol.41
-
-
Scorpio, A.1
Lindholm-Levy, P.2
Heifets, L.3
Gilman, R.4
Siddiqi, S.5
Cynamon, M.6
Zhang, Y.7
-
66
-
-
0001331161
-
History of the development of rifampin
-
Sensi P. 1983. History of the development of rifampin. Rev Infect Dis 5: S402–S406.
-
(1983)
Rev Infect Dis
, vol.5
, pp. S402-S406
-
-
Sensi, P.1
-
67
-
-
0014022737
-
Structure-activity studies leading to ethambutol, a new type of antituberculous compound
-
Shepherd RG, Baughn C, Cantrall ML, Goodstein B, Thomas JP, Wilkinson RG. 1966. Structure-activity studies leading to ethambutol, a new type of antituberculous compound. Ann N Y Acad Sci 135: 686–710.
-
(1966)
Ann N Y Acad Sci
, vol.135
, pp. 686-710
-
-
Shepherd, R.G.1
Baughn, C.2
Cantrall, M.L.3
Goodstein, B.4
Thomas, J.P.5
Wilkinson, R.G.6
-
68
-
-
80052904114
-
Characteristics of embB mutations in multidrugresistant Mycobacterium tuberculosis isolates in Henan, China
-
Shi D, Li L, Zhao Y, Jia Q, Li H, Coulter C, Jin Q, Zhu G. 2011a. Characteristics of embB mutations in multidrugresistant Mycobacterium tuberculosis isolates in Henan, China. J Antimicrob Chemother 66: 2240–2247.
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 2240-2247
-
-
Shi, D.1
Li, L.2
Zhao, Y.3
Jia, Q.4
Li, H.5
Coulter, C.6
Jin, Q.7
Zhu, G.8
-
69
-
-
81155160151
-
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis
-
Shi W, Zhang X, Jiang X, Yuan H, Lee JS, Barry CE III, Wang H, Zhang W, Zhang Y. 2011b. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science 333: 1630–1632.
-
(2011)
Science
, vol.333
, pp. 1630-1632
-
-
Shi, W.1
Zhang, X.2
Jiang, X.3
Yuan, H.4
Lee, J.S.5
Barry, C.6
Wang, H.7
Zhang, W.8
Zhang, Y.9
-
70
-
-
63549144228
-
Emb Nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol
-
Srivastava S, Ayyagari A, Dhole TN, Nyati KK, Dwivedi SK. 2009. emb Nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol. Int J Med Microbiol 299: 269–280.
-
(2009)
Int J Med Microbiol
, vol.299
, pp. 269-280
-
-
Srivastava, S.1
Ayyagari, A.2
Dhole, T.N.3
Nyati, K.K.4
Dwivedi, S.K.5
-
71
-
-
0024431530
-
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
-
Takayama K, Kilburn JO. 1989. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 33: 1493–1499.
-
(1989)
Antimicrob Agents Chemother
, vol.33
, pp. 1493-1499
-
-
Takayama, K.1
Kilburn, J.O.2
-
72
-
-
0015373050
-
Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis
-
Takayama K, Wang L, David HL. 1972. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2: 29–35.
-
(1972)
Antimicrob Agents Chemother
, vol.2
, pp. 29-35
-
-
Takayama, K.1
Wang, L.2
David, H.L.3
-
73
-
-
0016529811
-
Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis
-
Takayama K, Schnoes HK, Armstrong EL, Boyle RW. 1975. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J Lipid Res 16: 308–317.
-
(1975)
J Lipid Res
, vol.16
, pp. 308-317
-
-
Takayama, K.1
Schnoes, H.K.2
Armstrong, E.L.3
Boyle, R.W.4
-
74
-
-
0018748164
-
Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis
-
Takayama K, Armstrong EL, Kunugi KA, Kilburn JO. 1979. Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother 16: 240–242.
-
(1979)
Antimicrob Agents Chemother
, vol.16
, pp. 240-242
-
-
Takayama, K.1
Armstrong, E.L.2
Kunugi, K.A.3
Kilburn, J.O.4
-
75
-
-
0027538104
-
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
-
Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341: 647–650.
-
(1993)
Lancet
, vol.341
, pp. 647-650
-
-
Telenti, A.1
Imboden, P.2
Marchesi, F.3
Lowrie, D.4
Cole, S.5
Colston, M.J.6
Matter, L.7
Schopfer, K.8
Bodmer, T.9
-
76
-
-
0030913996
-
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
-
Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, Musser JM, Jacobs WR Jr. 1997. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3: 567– 570.
-
(1997)
Nat Med
, vol.3
-
-
Telenti, A.1
Philipp, W.J.2
Sreevatsan, S.3
Bernasconi, C.4
Stockbauer, K.E.5
Wieles, B.6
Musser, J.M.7
Jacobs, W.R.8
-
78
-
-
20944448468
-
Microbial metabolomics: Replacing trial-and-error by the unbiased selection and ranking of targets
-
van der Werf MJ, Jellema RH, Hankemeier T. 2005. Microbial metabolomics: Replacing trial-and-error by the unbiased selection and ranking of targets. J Ind Microbiol Biotechnol 32: 234–252.
-
(2005)
J Ind Microbiol Biotechnol
, vol.32
, pp. 234-252
-
-
Van Der Werf, M.J.1
Jellema, R.H.2
Hankemeier, T.3
-
79
-
-
34548605361
-
Microbial metabolomics: Toward a platform with full metabolome coverage
-
van der Werf MJ, Overkamp KM, Muilwijk B, Coulier L, Hankemeier T. 2007. Microbial metabolomics: Toward a platform with full metabolome coverage. Anal Biochem 370: 17–25.
-
(2007)
Anal Biochem
, vol.370
, pp. 17-25
-
-
Van Der Werf, M.J.1
Overkamp, K.M.2
Muilwijk, B.3
Coulier, L.4
Hankemeier, T.5
-
80
-
-
35848935866
-
The mechanism of isoniazid killing: Clarity through the scope of genetics
-
Vilcheze C, Jacobs WR Jr. 2007. The mechanism of isoniazid killing: Clarity through the scope of genetics. Annu Rev Microbiol 61: 35–50.
-
(2007)
Annu Rev Microbiol
, vol.61
, pp. 35-50
-
-
Vilcheze, C.1
Jacobs, W.R.2
-
81
-
-
33748469322
-
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
-
Vilcheze C, Wang F, Arai M, Hazbon MH, Colangeli R, Kremer L, Weisbrod TR, Alland D, Sacchettini JC, Jacobs WR Jr. 2006. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 12: 1027–1029.
-
(2006)
Nat Med
, vol.12
, pp. 1027-1029
-
-
Vilcheze, C.1
Wang, F.2
Arai, M.3
Hazbon, M.H.4
Colangeli, R.5
Kremer, L.6
Weisbrod, T.R.7
Alland, D.8
Sacchettini, J.C.9
Jacobs, W.R.10
-
82
-
-
0015469593
-
Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis
-
Wang L, Takayama K. 1972. Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2: 438–441.
-
(1972)
Antimicrob Agents Chemother
, vol.2
, pp. 438-441
-
-
Wang, L.1
Takayama, K.2
-
83
-
-
0015119823
-
Actions of the rifamycins
-
Wehrli W, Staehelin M. 1971. Actions of the rifamycins. Bacteriol Rev 35: 290–309.
-
(1971)
Bacteriol Rev
, vol.35
, pp. 290-309
-
-
Wehrli, W.1
Staehelin, M.2
-
84
-
-
0033520469
-
Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid
-
Wilming M, Johnsson K. 1999. Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid. Angew Chem Int Ed Engl 38: 2588–2590.
-
(1999)
Angew Chem Int Ed Engl
, vol.38
, pp. 2588-2590
-
-
Wilming, M.1
Johnsson, K.2
-
85
-
-
0001971349
-
Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid
-
Winder F. 1960. Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid. Am Rev Respir Dis 81: 68–78.
-
(1960)
Am Rev Respir Dis
, vol.81
, pp. 68-78
-
-
Winder, F.1
-
86
-
-
0014841450
-
Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis
-
Winder FG, Collins PB. 1970. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J Gen Microbiol 63: 41–48.
-
(1970)
J Gen Microbiol
, vol.63
, pp. 41-48
-
-
Winder, F.G.1
Collins, P.B.2
-
87
-
-
0014776244
-
Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope
-
Winder FG, Collins P, Rooney SA. 1970. Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope. Biochem J 117: 27P.
-
(1970)
Biochem J
, vol.117
, pp. 27
-
-
Winder, F.G.1
Collins, P.2
Rooney, S.A.3
-
88
-
-
13844319812
-
The magic bullets and tuberculosis drug targets
-
Zhang Y. 2005. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 45: 529–564.
-
(2005)
Annu Rev Pharmacol Toxicol
, vol.45
, pp. 529-564
-
-
Zhang, Y.1
-
89
-
-
0037252098
-
The curious characteristics of pyrazinamide: A review
-
Zhang Y, Mitchison D. 2003. The curious characteristics of pyrazinamide: A review. Int J Tuberc Lung Dis 7: 6–21.
-
(2003)
Int J Tuberc Lung Dis
, vol.7
, pp. 6-21
-
-
Zhang, Y.1
Mitchison, D.2
-
90
-
-
0032936728
-
Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide
-
Zhang Y, Scorpio A, Nikaido H, Sun Z. 1999. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Bacteriol 181: 2044–2049.
-
(1999)
J Bacteriol
, vol.181
, pp. 2044-2049
-
-
Zhang, Y.1
Scorpio, A.2
Nikaido, H.3
Sun, Z.4
-
91
-
-
0242437861
-
Mode of action of pyrazinamide: Disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid
-
Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z. 2003. Mode of action of pyrazinamide: Disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 52: 790– 795.
-
(2003)
J Antimicrob Chemother
, vol.52
-
-
Zhang, Y.1
Wade, M.M.2
Scorpio, A.3
Zhang, H.4
Sun, Z.5
-
92
-
-
84877267006
-
Advances in the development of new tuberculosis drugs and treatment regimens
-
Zumla A, Nahid P, Cole ST. 2013. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 12: 388–404.
-
(2013)
Nat Rev Drug Discov
, vol.12
, pp. 388-404
-
-
Zumla, A.1
Nahid, P.2
Cole, S.T.3
-
93
-
-
84896455574
-
New antituberculosis drugs, regimens, and adjunct therapies: Needs, advances, and future prospects
-
Zumla AI, Gillespie SH, Hoelscher M, Philips PP, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ. 2014. New antituberculosis drugs, regimens, and adjunct therapies: Needs, advances, and future prospects. Lancet Infect Dis 14: 327–340.
-
(2014)
Lancet Infect Dis
, vol.14
, pp. 327-340
-
-
Zumla, A.I.1
Gillespie, S.H.2
Hoelscher, M.3
Philips, P.P.4
Cole, S.T.5
Abubakar, I.6
McHugh, T.D.7
Schito, M.8
Maeurer, M.9
Nunn, A.J.10
|